Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Luteinizing Hormone Antikörper (AA 100-300)

Der Maus Monoklonal anti-Luteinizing Hormone Antikörper wird verwendet zum Nachweis von Luteinizing Hormone in Proben von Human. Er wurde validiert für IHC.
Produktnummer ABIN7859022
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Luteinizing Hormone Antikörper (AA 100-300) (ABIN7859022)

Target

Alle Luteinizing Hormone (LH) Antikörper anzeigen
Luteinizing Hormone (LH)

Reaktivität

  • 50
  • 15
  • 7
  • 3
  • 2
  • 2
  • 1
Human

Wirt

  • 28
  • 27
  • 3
  • 1
  • 1
Maus

Klonalität

  • 32
  • 28
Monoklonal

Konjugat

  • 37
  • 8
  • 6
  • 5
  • 2
  • 2
Dieser Luteinizing Hormone Antikörper ist unkonjugiert

Applikation

  • 37
  • 25
  • 20
  • 9
  • 7
  • 6
  • 6
  • 6
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Klon

LHCGR-7398
  • Bindungsspezifität

    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 100-300

    Verwendungszweck

    Luteinizing Hormone / Choriogonadotropin Receptor (LHCGR) Antibody

    Spezifität

    Recognizes a protein of 78-85 kDa, which is identified as Luteinizing hormone / choriogonadotropin receptor. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 100-300) of human LHCGR protein (exact sequence is proprietary)

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    Luteinizing Hormone (LH)

    Andere Bezeichnung

    Luteinizing Hormone

    Substanzklasse

    Hormone

    Hintergrund

    Gonadotropin receptor, GTHR-II, HHG, LCGR, LGR2, LH-R, LH/CG-R, LH/CGR, LHCGR, LHR, LHRHR, LSH-R, Luteinizing hormone receptor, Luteinizing hormone/choriogonadotropin receptor, Lutropin choriogonadotropic receptor, Lutropin-choriogonadotropic hormone receptor, ULG5

    HepG2 or Jurkat cells. Human ovarian carcinoma.

    Molekulargewicht

    78-85kDa

    Gen-ID

    3973, 468490
Sie sind hier:
Chat with us!